NFKB1 and cancer: A nanocarrier system carrying triptolide and the active metabolite of irinotecan, SN38 inhibited NF-κB in both gastric cancer cells and cancer-associated fibroblasts (CAF) to inhibit CAF-induced cancer cell proliferation, migration and SN38-resistance, resulting in significant reduction in tumor burden in vivo (197).